Cannula Market Size, Demand, Forecast To 2034

The global cannula market size was estimated at USD 204.22 million in 2025 and is anticipated to grow till USD 388.52 million by 2034 , growing at a CAGR of 7.45% from 2026 to 2034.

The market growth is primarily attributed to the increasing demand for oxygen therapy, the rising number of surgical procedures, preference for disposable cannulas to reduce infections, and technological advancements in cannula design for better patient safety and comfort.

Market Dynamics Increasing Prevalence of Respiratory Diseases

The increasing number of chronic respiratory disease patients is driving the demand for nasal cannulas.

• For example, in June 2025, as per the data reported by the World Health Organisation, more than 80 million people are affected by chronic respiratory diseases worldwide.

Such a factor underscores the critical need for effective and accessible respiratory solutions, which further drives the demand for nasal cannulas.

Innovations in cannula design are creating market opportunities by improving treatment outcomes.

• For example, in April 2024, as per the data reported in National Library of Medicine, researchers at Cornell University, U.S. developed a cannula that can automatically adjust its insulin dosage based on the blood glucose levels, without the electrical components.

Such innovations create opportunities by improving treatment outcomes and by increasing demand for safer and more efficient cannulas.

Key Highlights

• By Product , the market is segmented into Intravenous cannula, Nasal cannula and Others. The Intravenous cannula dominated the market in 2025 with a revenue share of 53%. This growth is attributed to the increasing adoption of intravenous therapies and rising prevalence of chronic diseases requiring long-term medication administration.
• By Application , the market is categorised into oxygen delivery, anaesthesia and surgery, blood sampling, and administration of medicine. The Oxygen delivery segment is estimated to grow at the fastest pace with a CAGR of 8.21%, owing to the rising prevalence of respiratory disorders and increasing adoption of home-based and hospital oxygen therapy.
• By Sizes, the market is categorised into 14G, 18G, 20G, 22G and others. The 18G segment dominated the market in 2025. The growth is attributed to the widespread use of 18G cannulas in various clinical procedures due to their optimal balance between flow rate and patient comfort.
• By Material, the market is categorised into plastic, stainless steel, and silicon. The plastic segment dominated the market in 2025. The growth is attributed to cost-effectiveness, lightweight nature, and disposability of plastic cannulas, which enhances patient safety.
• By End-User, the market is categorised into hospitals and clinics, ambulatory surgical centres and others. The hospitals and clinics segment dominated the market in 2025 with a market share of 55%. The growth is attributed to high volume of patient care services and the increasing number of surgical procedures in hospitals and clinics.
• Asia Pacific is estimated to be the fastest-growing region in the global market, with a CAGR of 92%. This growth is attributed to the rising geriatric population and the increasing prevalence of chronic and lifestyle-related diseases across the region.

Medtronic, BD, Edwards Lifesciences Corporation, LivaNova PLC, United Medical Supply, Boston Scientific Corporation, ICU Medical, Inc, B. Braun, Deltamed, Medikit Europe GmbH, Terumo Cardiovascular Systems Corporation, NIPRO, Vitality Medical, Inc, Cardinal Health, ANGIPLAST PRIVATE LIMITED, AdvaCare Pharma, Narang Medical Limited, Romsons, CONMED Corporation, Fisher & Paykel Healthcare Limited

• In September 2024, Braun Medical Inc. received FDA clearance for the Introcan Safety 2 Deep Access IV Catheter, which is the newest addition to the Introcan Safety 2 IV Cannula portfolio.